Binding of mistletoe lectins to cutaneous malignant melanoma: Implications for prognosis and therapy

Anticancer Research

Volumn 21, Issue 4 B, 2001, Pages 2883-2887

  Thies, A ^a   Pfuller U ^a   Schachner, M ^a   Horny, H P ^a   Moll, I ^a   Schumacher, U ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Melanoma; Metastasis; Mistletoe lectins; Viscum album agglutinin (VAA)

Indexed keywords

GLYCOCONJUGATE; MISTLETOE LECTIN 2; MISTLETOE LECTIN 3; UNCLASSIFIED DRUG; VISCUM ALBUM LECTIN;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; FEMALE; FOLLOW UP; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; LECTIN BINDING; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KILLER CELLS, NATURAL; LECTINS; LIFE TABLES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PLANT PREPARATIONS; PLANT PROTEINS; PROGNOSIS; SKIN NEOPLASMS; TOXINS, BIOLOGICAL;

EID: 0035174503     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cancer of the skin in the next century
2. Do HPA and PHA-L have the same binding pattern in metastasising human breast and colon cancers?
3. Predictive value of lectin binding on breast cancer recurrence and survival
4. Helix pomatia agglutinin is a useful prognostic indicator in colorectal carcinoma
5. Helix promatia agglutinin binding activity is a predictor of survival time for patients with gastric carcinoma
6. Cell biological and immunopharmacological investigations on the use of mistletoe lectin I (ML-I)
7. A nonradioactive assay for ribosome-inactivating proteins
8. Behaviour of lymphocyte subset and expression of activation markers to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients
9. Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defence system in vivo in rabbits and patients
10. Prophylactic effect of Korean mistletoe (Viscum album coloratum) extract on tumor metastasis is mediated by enhancement of NK cell activity
11. Lectin binding to normal and malignant breast tissue
12. Non-parametric estimation from incomplete observation
13. Position paper of the Melanoma Committee of the German Dermatological Society on cutaneous malignant melanoma, with recommendations for diagnosis, treatment and follow up. Status 1993/94
14. Mistletoe treatment for cancer. Review of controlled trials in humans
15. Unproven methods in oncology
16. Mistletoe lectins and behaviour of breast cancer
17. Is the binding of mistletoe lectins I and III a useful prognostic indicator in colorectal carcinoma?
18. Mistletoe Lectins (2)
19. Recombinant mistletoe lectin (rML) is successful in treating human ovarian cancer cells transplanted into severe combined immunodeficient (SCID) mice
20. Mistletoe lectins in attendant therapy of mammary carcinoma - First clinical experiences
21. Increased secretion of tumour necrosis factor-α, interleukin-1 and interleukin-6 by human mononuclear cells exposed to β-galactoside-specific lectin from clinically applied mistletoe extracts
22. Conventional cancer therapy: Promise broken or promise delayed?